Goldman Sachs’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-690
| Closed | -$45K | – | 5779 |
|
|
2021
Q3 | $45K | Buy |
+690
| New | +$45K | ﹤0.01% | 5213 |
|
|
2019
Q4 | – | Sell |
-490
| Closed | -$89K | – | 4397 |
|
|
2019
Q3 | $89K | Buy |
490
+93
| +23% | +$16.9K | ﹤0.01% | 4066 |
|
|
2019
Q2 | $158K | Sell |
397
-106
| -21% | -$42.2K | ﹤0.01% | 3929 |
|
|
2019
Q1 | $235K | Buy |
503
+106
| +27% | +$49.5K | ﹤0.01% | 3833 |
|
|
2018
Q4 | $191K | Sell |
397
-505
| -56% | -$243K | ﹤0.01% | 3753 |
|
|
2018
Q3 | $615K | Sell |
902
-804
| -47% | -$548K | ﹤0.01% | 3374 |
|
|
2018
Q2 | $1.17M | Buy |
+1,706
| New | +$1.17M | ﹤0.01% | 3123 |
|